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Abstract
 .A 66-kDa collagen fiber-associated protein RGD-CAP was isolated from a fiber-rich fraction of pig cartilage by
ultrafiltration and collagen-affinity chromatography. Amino acid sequencing and cDNA cloning indicated that the
RGD-CAP is identical or closely related to b ig-h3 protein which is induced in human adenocarcinoma cells by
 . transforming growth factor-b TGF-b Skonier, J., Neubauer, M., Madisen, L., Bennett, K., Plowman, G.D., and Purchio,
 . .A.F. 1992 DNA Cell. Biol. 11, 511–522 . The RGD-CAP, as well as b ig-h3, has the RGD sequence in the C-terminal
region. The native RGD-CAP bound to type I, II, and IV collagens even in the presence of 1 M NaCl. A recombinant
preparation of RGD-CAP expressed in Escherichia coli cells also bound to collagen but not to gelatin. The RGD-CAP
mRNA was expressed in chondrocytes throughout all stages, although the expression level was highest during the
prehypertrophic stage. In addition, TGF-b increased the RGD-CAP mRNA level in chondrocyte cultures. Since RGD-CAP
transcripts were found in most tissues, this novel collagen-binding protein may play an important role in cell-collagen
interactions in various tissues including developing cartilage.
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1 The nucleotide sequence data reported in this paper will
appear in the EMBL, GenBank and DDBJ Nucleotide Sequence
Databases under the accession number D55717.
1. Introduction
Collagen plays crucial roles as an anchoring sup-
port for adhesion, migration, proliferation and differ-
entiation of chondrocytes. Chondrocytes maintained
on collagen-coated dishes grow faster and synthesize
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proteoglycans at higher levels than on plastic tissue
w xculture dishes 1 . Furthermore, ascorbic acid is es-
sential for the expression of terminal differentiation-
w xrelated genes by chondrocytes 2–4 . Accordingly,
the expression of partially deleted or mutated type II
collagen genes or a partially deleted type X collagen
gene causes a structural derangement of chondrocyte
w xcolumns in growth plates 5–7 .
Collagen binds to the cell via various integrins
1 2 v w xsuch as a b , a b and a b 8–10 , and indirectly1 1 5
 .via collagen fiber-associated proteins CAPs such as
fibronectin and laminin. The indirect collagen-cell
interaction may be more important for rapid cell
changes in developing cartilage, because collagen
itself is stable. A number of proteins present in
w x w xcartilage such as fibronectin 11 , laminin 11 , os-
w x w xteonectinrSPARC 12,13 , decorin 14 and
w xcartilage-matrix protein 15 bind to collagen in vitro.
These CAPs may have different roles during cartilage
development and repair. The purpose of this study
was to find another CAP in cartilage. We digested
minced cartilage with proteases, homogenized the
insoluble material in the presence of detergent, then
obtained crude collagen fibers after extensive wash-
 .Fig. 1. The appearance of cartilage-matrix fibers A and collagen-affinity chromatography of proteins in the fiber-rich fraction, bovine
 .serum albumin, and crude cartilage extracts B . A, Cartilage-matrix fibers were isolated from growth plates of newborn pigs by enzyme
digestion and mechanical means as described in Section 2. Bar, 4 mm. B, Proteins in the fiber fraction were resolved on SDS-PAGE gels,
 .  . and stained with silver lane 1 . Collagen was removed from the fiber fraction by ultrafiltration, and the filtrate -M 100 kDa lanesr
.  .  .2–4 was applied onto a collagen type II column. Proteins eluted from the column with 10 mM Tris-HCl pH 7.4 lane 2 or 10 mM
 .  .  .  .Tris-HCl pH 7.4 supplemented with 1 M NaCl lane 3 or 10 mM Tris-HCl pH 7.4 supplemented with 6 M urea lane 4 were resolved
 .  .on SDS-PAGE gels and stained with silver. Bovine serum albumin lanes 5–7 or crude cartilage extracts lanes 8–10 were applied onto
 .  .  .the collagen column, and proteins were eluted with 10 mM Tris-HCl pH 7.4 lanes 5, 8 or 10 mM Tris-HCl pH 7.4 with 1 M NaCl
 .  .  .lanes 6, 9 or 10 mM Tris-HCl pH 7.4 with 6 M urea lanes 7, 10 .
( )K. Hashimoto et al.rBiochimica et Biophysica Acta 1355 1997 303–314 305
ing. A 66-kDa protein, tentatively named RGD-CAP,
was isolated from the fiber fraction by collagen-affin-
ity chromatography.
Amino acid sequencing and cDNA cloning showed
that RGD-CAP is 93% identical with b ig-h3 which
is synthesized by human adenocarcinoma cells in
 .response to transforming growth factor-b TGF-b
w x16 . The RGD-CAP was also homologous with rat
 . w xosteoblast-specific factor-2 OSF-2 17 and
w xDrosophila fasciclin 1 18 . The b ig-h3 protein stim-
ulates the adhesion of various cells and inhibits tumor
w xgrowth 19–21 . However, it remains unknown
whether RGD-CAPrb ig-h3 binds to extracellular
matrix macromolecules. The results of this study
showed that the native and recombinant RGD-CAP
binds to collagen beads even in the presence of 1.5 M
NaCl, and conversely, that RGD-CAP beads bind to
collagen. The RGD-CAP mRNA was expressed in
the prehypertrophic stage in vitro and in vivo. Fur-
thermore, TGF-b markedly enhanced RGD-CAP
synthesis by articular chondrocytes. These findings
suggested that RGD-CAPrb ig-h3 mediates signals
from collagen fibers to chondrocytes during develop-
ment and repair.
2. Materials and methods
2.1. Preparation of collagen fibers and purification
of RGD-CAP
 .Rib growth plate cartilage wet weight, 2.8 g of
 .new born pigs was minced 0.5=0.5=0.5 mm3
and incubated at 378C in 30 ml of phosphate-buffered
 .saline PBS, calcium- and magnesium-free contain-
ing 0.1% trypsin and 0.1% EDTA for 1 h. The tissues
were incubated at 378C in 30 ml of Eagle’s medium,
a-modification a-MEM, flow Laboratories, McLean,
.VA containing 0.3 mgrml of crude collagenase
 .type IA, Sigma, St. Louis, MO for 1.5 h. The
reaction was stopped by adding 10 ml of a-MEM
containing 10% fetal bovine serum. Cells were dis-
persed from the tissues by pipetting, and filtered
 .through a nylon mesh 0.12 mm . Tissue debris re-
maining on the mesh was washed with PBS, then
dispersed in 10 ml of PBS containing 0.5% Triton
X-100 and protease inhibitors 1 mM phenylmethane-
sulfonyl fluoride, 10 mM amidinophenylmethanesul-
fonyl fluoride, 10 mM N-ethylmaleimide and 0.1
.mM pepstatin A using a glass homogenizer. The
suspension was centrifuged at 1000=g for 10 min.
The pellet was resuspended with the same buffer, and
further dispersed with a glass homogenizer. This
procedure was repeated five times. Finally, the pellet
 .was suspended in water and fibers dry weight, 5 mg
were precipitated by centrifugation at 1000=g for
 .10 min Fig. 1A .
 .The fibers 3 mg were dissolved in 0.2 ml of
Laemmli buffer and boiled for 3 min. Proteins in the
sample were resolved in an agarose gel ProSieve Gel
.System, Takara, Tokyo, Japan by electrophoresis.
The gel containing 50–70 kDa proteins was removed,
and proteins were released from the gel at 708C
according to the manufacturer’s manual. Proteins were
then separated in a polyacrylamide gradient gel 4–
.20% by SDS-PAGE, transferred to a PVDF mem-
w xbrane 22 , then stained with Coomassie brilliant
blue. The N-terminal amino acid sequences of the 64-
and 66-kDa proteins on the PVDF membrane were
determined using an automatic protein sequencer
 .Applied Biosystems 476A .
2.2. Binding of RGD-CAP to collagen
Collagen beads were prepared by incubating 1 ml
 .of Affigel-10 Bio-Rad, Richmond, CA with 1 ml of
PBS containing 5 mg type I, II or IV collagen
 .Koken, Osaka, Japan .
 .To purify RGD-CAP, the fibers dry weight, 1 mg
were dissolved in 0.5 ml of 10 mM Tris-HCl pH
.7.4 containing 4 M guanidine HCl and protease
 .  .inhibitors see above buffer A , then the solution
was filtered through a Centricon membrane M 100r
.kDa; Amicon, Beverly, MA to remove type II colla-
gen. The filtrate was concentrated to a small volume
 .  .-0.02 ml on a Centricon membrane M 10 kDa ,r
then protein was dissolved in 0.5 ml of 10 mM
Tris-HCl, pH 7.4.
Crude extracts were prepared by incubating carti-
 .lage growth plates from new born pig ribs with 20
volumes of buffer A at 48C for 48 h. Proteoglycans
 .the D1 fraction were removed by centrifugation in
 . w xbuffer containing CsCl 1.47 grml 23 . The D2-D4
fraction was used as a control for the collagen-bind-
ing assay.
 .The sample 0.5 ml of 10 mM Tris-HCl, pH 7.4
( )K. Hashimoto et al.rBiochimica et Biophysica Acta 1355 1997 303–314306
containing RGD-CAP, crude cartilage extracts 0.1
.  .mg protein or bovine serum albumin 0.1 mg was
applied onto a collagen-Affigel column 0.2 ml bed
.volume that was equilibrated with 10 mM Tris-HCl,
pH 7.4. The column was washed with 1 ml of the
same buffer, then with 1.5 ml of the same buffer
containing 1 M NaCl. Protein was eluted from the
 .column with 0.8 ml of 10 mM Tris HCl pH 7.4
containing 6 M urea. Proteins in these fractions were
concentrated on a membrane Centricon, M 10 kDa,r
.Amicon, Beverly, MA and dissolved with 30 ml of
 .Laemmli buffer. Proteins in the samples 2 ml were
resolved by SDS-PAGE and stained with silver.
2.3. Cell culture
Chondrocytes were isolated from the femur knee
w xjoint cartilage of new born pigs as described 24 ,
except that minced cartilage was incubated with a-
MEM containing 0.5 mgrml of crude collagenase
 .type IA, Sigma, St. Louis for 2.5 h. The cells were
seeded at 105 cells per 3.5 cm plastic tissue culture
dish coated with type I collagen and maintained in 2
ml of a-MEM containing 10% fetal bovine serum,
50 mgrml of ascorbic acid, 32 Urml of penicillin,
 .and 40 mgrml of streptomycin medium A . Ascor-
 .bic acid 50 mgrml was added every other day.
Alternatively, cells were isolated from the rib growth
w xplates of 4-week-old Japanese white rabbits 24 ,
seeded at 3=105 cells per dish as described above
and maintained in 2 ml of medium A.
2.4. Molecular cloning and nucleotide sequencing of
RGD-CAP
Three days after pig chondrocytes reached conflu-
ence, total RNA was extracted using guanidine thio-
w xcyanate 25 . To obtain a partial cDNA probe for
screening the full size cDNA for 66 kDa CAP, a 439
bp PCR product was generated from the total RNA
preparation by RT-PCR using a pair of degenerate
primers based on the nucleotide sequence of b ig-h3
w x XcD N A 1 6 . T h e u p stream o lig o 5 -
GCTGTGCAGAAGGTTATTGGCA-3X corresponded
to nucleotides 195–216, and the down stream oligo
5X-GGTACATAGAGGTGAGGGTCAT-3X corre-
sponded to complementary nucleotides 612–633 of
b ig-h3. RT-PCR proceeded using the Gene Amp
 .PCR System 2400 Perkin-Elmer, Foster City, CA
 .and the GeneAmp RNA PCR kit Perkin-Elmer . The
PCR product of the correct size was subcloned into
 .pCRII vector Stratagene, La Jolla, CA and identi-
fied by means of sequencing using dideoxy chain
w xtermination 26 with the modifications of 7-deaza-
w x w xdGTP 27 and Sequenase 28 .
 .qPoly A RNA was used to construct cDNA li-
braries. Double-stranded cDNA was constructed us-
ing the Time Saver cDNA synthesis kit Pharmacia
.Fine Chemicals, Uppsala, Sweden . The cDNA was
ligated to EcoRI adapter and size-fractionated on a
Sephacryl S400 spun column. Fragments larger than
0.4 kbp were collected and ligated to EcoRI-digested
 .lZAP arms Stratagene, La Jolla, CA . The ligated
DNAs were packaged using Gigapack II Gold Pack-
 .aging Extract Stratagene , and the resultant phage
particles were plated on Escherichia coli XL1-Blue.
The cDNA library was screened using the 32P-labeled
439 bp PCR product obtained above. The largest
cDNA clone obtained from lZAP library had a 2.8
kbp insert. The isolated clones were converted to
pBluescript phagemid clones by in vivo excision
according to the product manual and the resulting
plasmid clones were restriction enzyme mapped and
sequenced. To sequence these clones, DNA frag-
ments were generated by digestion with restriction
enzymes and cloned into pBluescript SK-vectors.
Double strand DNA was prepared and sequenced by
dideoxy chain termination.
2.5. cDNA probes for type X collagen, alkaline phos-
phatase, and G3PDH
 .Type X collagen cDNA 602 bp and alkaline
 .phosphatase cDNA 483 bp were obtained by RT-
PCR from total RNA of rabbit cartilage using pairs of
degenerate oligonucleotides: 5X-CCCAACACCAA-
GACACAGTT-3X and 5X-ATCACCTTTGATGC-
CTGGCT-3X for type X collagen, as well as 5X-AG-
GCTGGAGATGGACAAGTT-3X and 5X-TG-
GTCAATCCTGCCTCCTTC-3X for alkaline phos-
phatase. These were synthesized based on the nu-
w xcleotide sequences of human type X collagen 29
w xand rat alkaline phosphatase 30 cDNAs, respec-
tively. Glyceraldehyde 3-phosphate dehydrogenase
 .  .G3PDH cDNA 613 bp was also obtained by
RT-PCR from the total RNA of pig cartilage using a
( )K. Hashimoto et al.rBiochimica et Biophysica Acta 1355 1997 303–314 307
pair of degenerate oligonucleotides, 5X-GTCAAG-
GCTGAGAACGGGAA-3X and 5X-TCCACCACC-
CTGTTGCTGTA-3X, that were synthesized based on
w xthe sequence of rabbit G3PDH cDNA 31 . The
correct PCR products were subcloned into pCRII
 .vector Stratagene and identified by sequencing by
means of dideoxy chain termination.
2.6. Northern and Southern blots
Total RNA was extracted from pig and rabbit
w xchondrocyte cultures 25 . Ten micrograms of total
RNA for each sample was denatured in 2.2 M
formaldehyde and 50% formamide, resolved by elec-
trophoresis on a 1% agarose gel containing 2.2 M
w xformaldehyde 32 , then transferred to a Nytran mem-
 .brane Schreicher and Schuell, Keene, NH with
20=SSC as the transfer buffer. The membrane was
baked at 808C for 1 h and incubated in a prehy-
bridization solution containing 6 = SSC, 5 =
Denhardt’s solution, 10 mM EDTA, 0.5% SDS, and
0.1 mgrml sonicated salmon sperm DNA at 688C for
1 h. Hybridization proceeded in the same buffer
32  .containing P-labeled partial cDNA insert 439 bp
at 688C for 15 h. The membrane was washed with
0.2=SSC containing 0.1% SDS and exposed to
X-ray film. The radioactivity was measured using a
 .laser image analyzer Fujix, BAS2000 .
The mRNA levels were also estimated by RT-
PCR-Southern blotting using the pairs of degenerate
primers. The PCR products 23 and 29 cycles for
.RGD-CAP and G3PDH, respectively were separated
on an agarose gel, then transferred to Nytran. Hy-
bridization proceeded under the same conditions as
described above.
2.7. Expression of pig recombinant RGD-CAP in E.
coli
 .A SacI fragment 1456 bp was excised from
clone p4 and inserted into the SacI site of the expres-
 .sion vector pET-28a Novagen to give a expression
plasmid encoding a truncated peptide corresponding
185 to 667 amino acids of RGD-CAP. The inserted
site is located between 113 nucleotides down stream
from the initiation codon and 61 nucleotides up-
stream from the termination codon of the pET28a
cloning site. The constructed vector thus encodes a
truncated and fused protein with a theoretical molecu-
lar weight of 58 407. The clone named pET-CAP
containing the truncated insert in the correct orienta-
tion was selected and sequenced to ensure that muta-
tions were not inadvertently introduced during the
cloning procedure. The Escherichia coli strain
 .  .HMS174 DE3 Novagen transformed with pET-
CAP was shaken in Luria-Bertani medium containing
30 mgrml kanamycin at 378C until the OD reached600
0.6. The T7 lac promoter was then induced with 1
mM IPTG and the incubation was continued for 3 h.
The cells were harvested and the inclusion bodies
w xwere obtained as described by Marston 33 . The
inclusion bodies were dissolved in 7 M urea and 10
 .mM Tris-HCl pH 7.4 , then dialyzed with 10 mM
 .Tris-HCl pH 7.4 . The sample was applied to an
 .FPLC Superose 6 column 10=300 mm, Pharmacia
 .equilibrated with 10 mM Tris-HCl pH 7.4 . The
fractions containing recombinant 58 kDa RGD-CAP
were collected and applied to an FPLC Mono Q
 .column 5=50 mm equilibrated with 10 mM Tris-
 .HCl pH 7.4 . After washing with 10 mM Tris-HCl
 .pH 7.4 , the recombinant protein was eluted with 10
 .mM Tris-HCl pH 7.4 containing 2 M NaCl. Recom-
binant b-galactosidase was also prepared as a control
according to the product manual. The recombinant
proteins 0.02 mg in 0.5 ml of 10 mM Tris HCl
.buffer, pH 7.4 were applied to a collagen-Affigel
column, as described above.
2.8. Preparation of RGD-CAP beads
Recombinant RGD-CAP and b-galactosidase were
separately bound to a metal chelation resin as fol-
lows, since the recombinant proteins produced by the
pET28a expression vector have a stretch of 6 histi-
dine residues at the N-terminal region, that binds to
divalent cations immobilized on the metal chelation
resin. 2 ml of 50 mM NiSO was added to a column4
 .of Chelating Sepharose 6B 0.2 ml bed volume
 .Pharmacia . The column was washed with 2 ml of
 .water and 2 ml of 10 mM Tris-HCl pH 7.4 contain-
 . ing 7 M urea buffer B . The recombinant proteins 2
.mg in buffer B were applied to the column equili-
brated with buffer B. The column was washed with 2
ml of buffer B, then with 2 ml of 10 mM Tris-HCl
 .pH 7.4 containing 0.15 M NaCl and 0.1% CHAPS
 .buffer C . For binding assays, one ml of buffer C
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Fig. 2. Restriction enzyme map of the six representative cDNA clones encoding pig RGD-CAP. P1, P4, P9, P11, P14 and P34 are
representative cDNA clones for pig RGD-CAP cDNA. P, Pst I; N, NcoI; S, SacI; H, HindIII; B, BamHI, and E, EcoRI. Thick bar
indicates the coding region.
 .containing collagen or gelatin 50 mgrml was ap-
plied to the column equilibrated with buffer C. After
washing the column with 0.5 ml of buffer C, protein
was eluted from the column with 2 ml of buffer C
containing 1.5 M NaCl, and 2 ml of buffer C contain-
 .ing 7 M urea. Fractions 0.5 ml were collected, and
 .aliquots 15 ml were resolved by SDS-PAGE.
3. Results
3.1. Isolation of RGD-CAP from cartilage-matrix
fibers
Crude collagen fibers were isolated from pig
growth plates, as described in Materials and Methods
 .Fig. 1A . The collagen fiber-rich fraction contained
 .type II collagen 120 kDa and 64–66 kDa protein
 .Fig. 1B . The fibers were insoluble in water, but
completely solubilized after an incubation with pure
 .bacterial collagenase Sigma, type VII, 1 Urml at
378C for 15 h. This procedure caused 120 kDa colla-
gen to disappear without changes in other proteins
 .data not shown . These findings suggested that non-
collagenous proteins were so tightly attached to the
insoluble collagen fibers that they were resistant to
proteases and homogenization.
After removing type II collagen by ultrafiltration
 .M 100 kDa cut off , the non-collagenous proteinsr
in the fiber fraction were separated by collagen-affin-
ity chromatography. The 64–66 kDa protein RGD-
 .Fig. 3. A comparison among pig RGD-CAPrb ig-h3, rat osteoblast-specific factor-2 OSF-2 and Drosophila fasciclin I. A, Four
repeated domains are shown by open boxes. Hatched and cross-hatched bars represent highly conserved regions H1 and H2,
.  .respectively . B, The amino acid sequences of H1 and H2 in the four repeated domains I, II, III, and IV of pig RGD-CAP, as well as the
distance between H1 and H2, are shown.
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Fig. 4. Binding of recombinant RGD-CAP to collagen beads.
Recombinant RGD-CAP or recombinant b-galactosidase 0.02
.mg in 0.5 ml of 10 mM Tris-HCl buffer, pH 7.4 was applied to a
type I collagen-Affigel column as described in the legend to Fig.
1B. These proteins were eluted from the column with 10 mM
 .  .  .Tris-HCl pH 7.4 lane 2 or 10 mM Tris-HCl pH 7.4 with 1.5
 .  .M NaCl lane 3 or 10 mM Tris-HCl pH 7.4 with 7 M urea
 .  .lane 4 . The proteins before lane 1 and after the collagen-affin-
 .ity chromatography lanes 2–4 were concentrated to a small
 .  .volume 0.03 ml , and aliquots 2 ml were resolved by SDS-
PAGE, then stained with silver nitrate.
.CAP bound to the type II collagen-Affigel even in
the presence of 1 M NaCl, and was eluted with 6 M
urea, whereas proteins of M -30 kDa did not bindr
 .to the gel Fig. 1B . Crude cartilage extracts or
bovine serum albumin also did not bind to the gel
 .Fig. 1B . Similar results were obtained using the
type I or IV collagen-Affigel column data not
.shown .
3.2. cDNA isolation and nucleotide sequencing
The 64 and 66-kDa RGD-CAPs were separated by
agarose-gel electrophoresis and SDS-PAGE, and their
Fig. 5. Binding of collagen and gelatin to RGD-CAP beads. Type
 .  .  .I collagen A, B or gelatin C 1 ml, 50 mgrml was applied to
 .a column of RGD-CAP- A, C or b-galactosidase-bound beads
 .B as described in Section 2. After washing the column with 0.5
 .ml of 10 mM Tris-HCl pH 7.4 containing 0.15 M NaCl and
0.1% CHAPS, protein was eluted with 2 ml of the same buffer
containing 1.5 M NaCl, and then 2 ml of the buffer containing 7
 . M urea. Fractions 0.5 ml were collected and the aliquots 15
.ml were analyzed by SDS-PAGE. Lane 1, samples before appli-
cation to the column; lane 2, proteins that passed through the
column; lanes 3–6, proteins eluted with 1.5 M NaCl; lanes 7–10,
proteins eluted with 7 M urea. This collagen sample contained a
 .high molecular mass form perhaps a dimer in addition to 120
kDa collagen.
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N-terminals were sequenced. These proteins have the
N-terminal amino acid sequences of GPAKSPYQLV-
LQHSRLRG- and GPAKSPYQLVLQHXRLXG-.
The difference in their size may be due to posttrans-
 .lational modification s other than N-terminal cleav-
age. The sequence of RGD-CAP was identical with
the N-terminal sequence of human mature b ig-h3
protein produced by COS cells transfected with b ig-
w xh3 16 . These cells also secrete 66 and 68-kDa
proteins immunoreactive to anti-b ig-h3 antiserum
w x19 .
On the basis of this information, we obtained a
439 bp-PCR product using primers corresponding to
b ig-h3 and total RNA from pig chondrocytes by
RT-PCR. Using the PCR product as a probe, thirty
individual clones were isolated from about 8=105
pig chondrocyte cDNA clones by plaque hybridiza-
tion, subcloned and restriction enzyme mapped Fig.
.2 . As none of these clones covered the entire RGD-
CAP mRNA, the total structure was constructed by
overlapping the sequences of several clones. The
2819 bp-nucleotide sequence of RGD-CAP thus de-
termined EMBLrGenbankrDDBJ accession No.
.D55717 seemed to cover the entire mRNA, since
Northern blots showed that the size of the RGD-CAP
 .mRNA is about 2.8 kb see below . The open reading
frame starts at 171st nucleotide, and encodes a pep-
 .tide consisting of 683 amino acids M 74 457 . Ther
deduced amino acid sequence from 24 through 41
was identical with the N-terminal sequence of the 64
and 66-kDa proteins, establishing that the peptide
removed by processing comprised amino acid residues
1 through 23. The cleaved peptide contains the hy-
drophobic amino acid residues characteristic of the
presequence of a secretory protein. The mature RGD-
CAP comprises 660 amino acid residues correspond-
ing to a molecular weight of 72 221, which is close to
the M of 66 kDa of RGD-CAP estimated by SDS-r
w xPAGE. As indicated for human b ig-h3 16 , the
predicted amino acid sequence of pig RGD-CAP has
Fig. 6. The effect of TGF-b on the RGD-CAP mRNA level in cultured chondrocytes. Pig articular chondrocytes were seeded and
maintained as described in Section 2. Three days after the cells reached confluence, they were incubated in fresh medium A for another
72 h in the presence or absence of TGF-b-1 at 3 ngrml. The medium was replaced at 48 h. These cells were incubated with TGF-b-1 at 3
 .ngrml in medium A for 0–72 h before the end of incubation. The mRNA levels were estimated by Northern blotting A and
 .RT-PCR-Southern blotting B using cDNA probes for RGD-CAP and G3PDH as described in Section 2. The radioactivity levels in
mRNA bands were quantified using a Fuji Film Bioimaging Analyzer, and the ratio of radioactivity in RGD-CAP to G3PDH was
 .determined C,D .
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also fourfold repeat domains and an RGD sequence
that may serve as a recognition sequence for integrins
 .in the fourth domain Fig. 3 .
 .A computer homology search EMBL data base
indicated that pig RGD-CAP is 89 and 93% identical
in the nucleotide and amino acid sequences to human
w xb ig-h3 16 , and 86 and 91% identical to mouse
w x  .b ig-h3, respectively 19 Fig. 3 . RGD-CAPrb ig-h3
contains the RGD sequence in the C-terminal region.
In addition, pig RGD-CAP is 45 and 22% identical in
the amino acid sequence to rat osteoblast-specific
 .factor-2 OSF-2 and Drosophila fasciclin I, respec-
w xtively 16–19 . These proteins also have the four
repeats, although they do not contain the RGD se-
quence. All repeats of RGD-CAPr b ig-h3, OSF-2
and fasciclin I have two short, highly conserved
 . w x  .regions H1, H2 16–19 Fig. 3 . For example, the
H1 in the repeat I of pig RGD-CAP was 90% identi-
cal in the amino acid sequence to that in the repeat I
of rat OSF-2 and the repeat III of Drosophila fasci-
clin I. The H2 in the repeat I of RGD-CAP was 72
and 66% identical to that in the repeat II of OSF-2
and the repeat IV of fasciclin I, respectively. The
 .distance 77 to 104 amino acids between H1 and H2
 .in each repeat was also conserved Fig. 3 .
3.3. Binding of recombinant RGD-CAP to collagen
To confirm the collagen-binding capacity of RGD-
CAP, a recombinant RGD-CAP sample was applied
 .to a type I collagen-Affigel column Fig. 4 , or type I
collagen was applied to a column of RGD-CAP-Sep-
 .harose Fig. 5 . In these assays, most of the RGD-CAP
consistently bound to collagen even in the presence
 .of 1.5 M NaCl Figs. 4 and 5 . In contrast, the
recombinant b-galactosidase did not bind to colla-
gen, irrespective of the presence or absence of 1.5 M
 .NaCl Figs. 4 and 5 . RGD-CAP did not bind to
gelatin type I collagen denatured by boiling for 5
.  .min in 10 mM Tris HCl, pH 7.4 Fig. 5C .
3.4. Expression of RGD-CAP mRNA in cartilage in
˝i˝o and in ˝itro
Northern blots showed that in chondrocyte cul-
tures, TGF-b increases the RGD-CAP mRNA level
5-fold 24 h after it is added to the cultures Fig.
.6AC . Similar results were obtained by RT-PCR
 .Southern blotting Fig. 6BD . Cytokine stimulation of
RGD-CAP expression was maximal at 3 ngrml data
.not shown .
We then examined the changes in the RGD-CAP
mRNA level during chondrocyte cytodifferentiation
using rabbit growth-plate chondrocytes in mass cul-
ture. These cells produce the cartilage matrix type II
Fig. 7. Changes in the RGD-CAP mRNA level during chondro-
cyte cytodifferentiation. Rabbit growth-plate chondrocytes were
seeded at high density and maintained as described in Section 2.
Total RNA was prepared at the indicated days after seeding.
 .  .RGD-CAP A and G3PDH B mRNA levels were estimated by
RT-PCR-Southern blotting as described in Section 2. The levels
 .  .of alkaline phosphatase C and type X collagen D were
examined by Northern blotting. The radioactivity levels in hy-
bridized areas were quantified using a Fuji Film Bioimaging
Analyzer, and the ratio of the radioactivity in RGD-CAP to that
 .in G3PDH was determined E .
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.collagen and aggrecan at high levels after the cessa-
tion of cell division. Thereafter, the cells synthesize
alkaline phosphatase and type X collagen, markers of
terminal chondrocytes, at levels as high as those in
w xthe growth plate in vivo 34 . The expression of the
RGD-CAP mRNA was low during the proliferating
 .stage day 7 , increased in the matrix-forming stage
 .day 14 , then decreased gradually during the hyper-
 .  .trophic stage days 21 and 28 Fig. 7 . In these
cultures, alkaline phosphatase and type X collagen
transcripts were found on days 21 and 28. We con-
firmed that the RGD-CAP mRNA was expressed in
the growth plate of new born pigs in vivo, and that
this level was higher than or equal to that in the lung,
heart, spleen, kidney, liver and adrenal glands data
.not shown . The RGD-CAP mRNA level was far
lower in the brain than in the other tissues tested
 .data not shown .
4. Discussion
The deduced amino acid sequence of pig RGD-
CAP is 91–93% identical with that of mouse or
human b ig-h3 protein, suggesting that RGD-CAP
and b ig-h3 are orthologous. The high homology
among these species suggests the importance of
RGD-CAPrb ig-h3. The sequence of pig RGD-CAP
was also similar to that of rat osteoblast-specific
 .factor-2 OSF-2 and of Drosophila fasciclin I
w x17,18 . Furthermore, fasciclin I, OSF-2 and RGD-
CAPrb ig-h3 have the two highly conserved regions
within the four internal repeated domains. The H1
and H2 regions are composed of hydrophobic amino
acids, forming a b-sheet-like structure. These regions
may interact with other macromolecules or maintain
an active conformation of these proteins. Fasciclin I
w xis found exclusively in nerve fibers 18 , and serves
w xas a homophilic adhesion molecule 35 . OSF-2 is
w xlocalized in bone, and its function is unknown 17 .
On the other hand, RGD-CAPrb ig-h3 is widely
distributed in various tissues except for the brain
w x .16,17 , this study .
RGD-CAPrb ig-h3 is expressed at high levels in
corneal epithelium but not in the connective tissues
w xsuch as the lens and the corneal stroma 20 . This
protein is also present in adult human skin, particu-
larly in the papillary dermis and in a band along the
w xgranular layer of the epidermis 21 . Although RGD-
CAPrb ig-h3 transcripts are found in most tissues,
some cell types seem to express this protein stage-
and site-dependently. TGF-b stimulates b ig-h3 ex-
w xpression in some tumor and normal cells 16 . This
induction of b ig-h3 may contribute to the TGF-b
suppression of tumor growth, because the overexpres-
sion of b ig-h3 in CHO cells reduces the growth rate
w xin vitro, as well as tumorgenesity in vivo 19 .
b ig-h3 may serve as an adhesion molecule, be-
cause b ig-h3 protein substrate stimulates fibroblast
w xadhesion 21 , whereas soluble b ig-h3 inhibits A549
w xcell adhesion 19 . The RGD motif near the C-
terminus of b ig-h3 may serve as an integrin binding
site and contribute to its cell-binding capacity. If
b ig-h3 regulates cell-matrix interactions like other
adhesion molecules, it may bind to the extracellular
matrix.
We showed here that RGD-CAP binds to various
collagens. Crude cartilage extracts did not bind to
collagen under similar conditions, suggesting a selec-
tive interaction between RGD-CAP and collagen.
RGD-CAP bound to collagen even in the presence of
1.0–1.5 M NaCl in the absence of other macro-
molecules. Thus RGD-CAP directly binds to collagen
in a non-ionic fashion. RGD-CAP bound to type I
collagen, but not the collagen boiled for 5 min. This
suggests that RGD-CAP binds to collagen fibers when
the collagen molecule is in the triple-helical confor-
mation but not when it is in random coil conforma-
 .tion. Collagenase MMP-1 also binds to various
collagens, but not to gelatin. On the other hand,
fibronectin binds to both collagens and gelatin. These
findings suggest that the action of RGD-CAP differs
from that of fibronectin during tissue inflammation
and tissue remodeling.
During development and chronic inflammation,
chondrocytes undergo migration, adhesion, prolifera-
tion and differentiation. Adhesion or anti-adhesion
molecules may be crucial for chondrogenesis and
cartilage repair. The syntheses of fibronectin and
 .osteonectin SPARC are enhanced in these processes
w x11,13,36–38 . It is also noteworthy that TGF-b in-
w x w xduces the syntheses of fibronectin 39 , SPARC 13
and RGD-CAP by chondrocytes, since TGF-b in-
duces chondrogenesis and cartilage repair in vivo.
Although chondrocytes expressed RGD-CAP mRNA
at all stages even in the absence of TGF-b , the
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expression of RGD-CAP was the highest during the
prehypertrophic stage. Our preliminary studies have
also immunolocalized RGD-CAP protein in the pre-
hypertrophic zone of chick embryo growth plates. We
are currently investigating the role of this protein in
skeletal development and repair.
In conclusion, the structure of RGD-CAPrb ig-h3
differs from any known collagen-binding proteins.
Furthermore, the binding of RGD-CAPrb ig-h3 to
native collagens is strong and specific. This novel
collagen-binding protein may play a role in mediating
signals from the extracellular matrix to various cells.
In cartilage, RGD-CAPrb ig-h3 may be involved in
endochondral bone formation.
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